SOTK 8-K: Press release on $2.8M medical coating systems order

Rhea-AI Filing Summary

Sono-Tek Corporation reported via an 8-K that it issued a press release announcing an order for medical device coating systems valued at $2.8 million.

The disclosure was furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure) and includes Exhibit 99.1, a press release dated October 13, 2025. The furnished information is not deemed filed under Section 18 of the Exchange Act.

Insights

Industrial Tech Analyst

Operationally positive: a disclosed $2.8 Million order signals tangible demand and near-term business activity, furnished via 8-K Items 2.02 and 7.01.

Sono-Tek Corporation reported an order for medical device coating systems valued at $2.8 Million on October 13, 2025. This is concrete commercial execution in the medical device segment, indicating active customer purchasing for its coating systems. The disclosure was furnished under Items 2.02 and 7.01 with an attached press release (Exhibit 99.1).

The company designated the information as "furnished," not "filed," which limits Section 18 liability and frames the update as informational rather than a full financial filing. While this is a single order disclosure, it reflects booked business tied to core products, which is operationally favorable.

Watch for follow-on disclosures that detail delivery status, revenue recognition within upcoming periods, and any related production or capacity updates in subsequent reports. The press release dated October 13, 2025 is the key source for specifics on the order scope and context.

false 0000806172 SONO TEK CORP 0000806172 2025-10-13 2025-10-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 13, 2025

Sono-Tek Corporation

(Exact name of registrant as specified in its charter)

Commission File Number: 001-40763

New York		14-1568099
(State of Incorporation)		(I.R.S. Employer ID No.)
2012 Route 9W, Milton, New York		12547
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (845) 795-2020

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value per share	SOTK	NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02: Results of Operations and Financial Condition.

Item 7.01: Regulation FD Disclosure

On October 13, 2025, Sono-Tek Corporation issued a press regarding an order for medical device coating systems valued at $2.8 Million which is attached as exhibit 99.1.

The information furnished pursuant to Item 2.02 and Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01: Financial Statements and Exhibits.

(d) Exhibits

99.1       Press release dated October 13, 2025

104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SONO-TEK CORPORATION

By: /s/ Stephen J. Bagley

Stephen J. Bagley

Chief Financial Officer

October 13, 2025

FAQ

What did SOTK announce in this 8-K?

Sono-Tek announced a press release regarding an order for $2.8 million of medical device coating systems.

When was the announcement made?

The press release and 8-K are dated October 13, 2025.

Which items does the 8-K cover?

The 8-K furnishes information under Item 2.02 and Item 7.01.

Is the information considered filed with the SEC?

No. The information is furnished and is not deemed filed under Section 18 of the Exchange Act or incorporated by reference.

What exhibit accompanies the filing?

Exhibit 99.1, the press release dated October 13, 2025.

What is Sono-Tek's trading symbol and exchange?

The common stock trades on NASDAQ under the symbol SOTK.